As part of the collaboration, the two organizations will use
"We are excited to have the opportunity to collaborate with
"We look forward to this collaboration enabling us to ultimately understand complex disease states and develop new diagnostic tests that provide answers for our clients and patients," says
For more information, please visit www.nanostring.com.
Doug Farrell, NanoString Technologies Inc., 206-602-1768, firstname.lastname@example.org Suzanne Ferguson, Mayo Clinic Laboratories, 507-284-5005, email@example.com
Source: NanoString Technologies, Inc.